| 产品详情 |
| Edit |   |
|---|
| Product Name | Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein, CF |
|---|
| Description | Purity >95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining. MW (observed): 62-77 kDa, reducing conditions. MW (theoretical): 49 kDa. The Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein from R&D Systems is derived from HEK293. The Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein has been validated for the following applications: Bioactivity. |
|---|
| Size | 100 ug |
|---|
| Concentration | n/a |
|---|
| Applications | Bioactivity |
|---|
| Other Names | B7-DC, bA574F11.2, Btdc, Butyrophilin B7-DC, Butyrophilin-like Protein, CD273, CD273 antigen, CD273PD-1 ligand 2, MGC142240, PD-1-ligand 2, PDCD1L2MGC142238, PDCD1LG2, PDL2, PDL2B7DC, PD-L2PDCD1 ligand 2, programmed cell death 1 ligand 2, Programmed death ligand 2 |
|---|
| Gene, Accession, CAS # | Gene ID: 102146227, Accession: XP_005581839 |
|---|
| Catalog # | 9178-PL-100 |
|---|
| Price | |
|---|
| Order / More Info | Recombinant Cynomolgus PD-L2/B7-DC Fc Chimera Protein, CF from R&D SYSTEMS, INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|